CounterPath (CPAH) Stock Is Up 500% In 3 Sessions

CounterPath CPAH Stock News

CounterPath, Corp. (NASDAQ: CPAH) is making a run for the top in the market today, gaining 30% early on and ratcheting up the growth that we’ve seen over the past three trading sessions to more than 500%.

The gains started after the company announced that it has entered into a new collaboration with Honeywell with the goal of launching a new product. Here’s what’s happening:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

CPAH Stock Rockets On Honeywell Collaboration

Late last week, CounterPath Corporation announced that it has entered into a new collaboration wtih Honeywell. The collaboration is centered around the creation and launch of a new product known as Smart Talk.

In the press release, CPAH said that the new service will allow for several features, including, but not limited to:

  • VoIP calls;
  • push-to-talk conversations;
  • instant messaging to one receiver or a group of colleagues; and
  • video calls.

Nonetheless, with the news coming out late last week, and the stock already seeing dramatic gains since, many are wondering just why the stock is climbing today.

The truth of the matter is that the gains are indeed the result of continued excitement about this deal, and for very good reason.

Think about it, a few sessions ago, CPAH was a stock that traded with relatively heavy short interest and a market cap of under $30 million. First and foremost, the dramatic gains are likely the result of a short squeeze with the Honeywell collaboration announcement providing the charge for the explosion.

Nonetheless, there’s good reason to be excited beyond the short squeeze.

Honeywell is a massive, highly-successful company. The company generates well over $40 billion per year and trades with a market cap of just under $130 billion, making it one of the largest companies in the world.

For CounterPath to have technology that attracts such a large player tells us a lot. First and foremost, Honeywell sees the potential for tremendous growth with the technology that CPAH has amassed.

Beyond that, through this collaboration, Honeywell will make resources available that CounterPath couldn’t dream of having available to it in the past. As a result, the new product is going to be something that neither CPAH or Honeywell would have been likely to accomplish in the past.

Finally, this is a mass-market stype product. It’s the type of product that, if it goes properly, has the potential to generate tremendous amounts of revenue. Of course, it would have to be to get Honeywell’s attention. Nonetheless, for CPAH and its investors, this agreement represents a ground breaking opportunity!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story!

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.